PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Guidelines : Psoriasis
Guidelines : Psoriasis
Additional Documents
Type
Document
Review Date
Other Drugs
- Acitretin
- Adalimumab
- Etanercept
- Infliximab
- Ustekinumab (Psoriasis)
- Secukinumab
- Apremilast
- Ixekizumab
- Brodalumab (Psoriasis)
- Dimethyl fumarate
- Guselkumab
- Tildrakizumab
- Certolizumab pegol
- Risankizumab
- Pimecrolimus
- Bimekizumab
- Deucravacitinib
Committee Recommendations
Date
Committee Name
Narrative
04 August 2021
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed the Psoriasis – Treatment choice for adults in Primary Care guidance. Please see below.